Liver transplantation in Germany

Liver Transplantation

Volumn 22, Issue 8, 2016, Pages 1136-1142

  Tacke, Frank ^a   Kroy, Daniela C ^a   Barreiros, Ana Paula ^b   Neumann, Ulf P ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b German Foundation for Organ Transplantation (DSO)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; ARTICLE; GERMANY; HEALTH CARE ACCESS; HOSPITAL ADMISSION; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL;

EID: 84979555121     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24461     Document Type: Article

References (27)

1. Wedemeyer H, Hofmann WP, Lueth S, Malinski P, Thimme R, Tacke F, Wiegand J. [ALT screening for chronic liver diseases: scrutinizing the evidence; in German]. Z Gastroenterol 2010;48:46–55.
2. Völzke H, Ittermann T, Schmidt CO, Baumeister SE, Schipf S, Alte D, et al. Prevalence trends in lifestyle-related risk factors. Dtsch Arztebl Int 2015;112:185–192.
3. Vermehren J, Schlosser B, Domke D, Elanjimattom S, Müller C, Hintereder G, et al. High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients. PLoS One 2012;7:e41206.
4. Wolffram I, Petroff D, Bätz O, Jedrysiak K, Kramer J, Tenckhoff H, et al.; for German Check-Up 35+ Study Group. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios. J Hepatol 2015;62:1256–1264.
5. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593–608.
6. Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014;21(suppl 1):60–89.
7. Westphal C, Doblhammer G. Projections of trends in overweight in the elderly population in Germany until 2030 and international comparison. Obes Facts 2014;7:57–68.
8. Giehle S. Facts about Germany. http://www.tatsachen-ueber-deutschland.de/en/society/main-content-08/social-security.html. Accessed April 2015.
9. Organisation for Economic Co-operation and Development. Gesundheitsausgaben 2015 in Deutschland. In. http://www.oecd.org/berlin/presse/Health-Statistics-Deutschland-Laendernotiz.pdf. Accessed April 2015
10. European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol 2016;64:433–485.
11. Bundesärztekammer. Richtlinien zur Organtransplantation gem. §16 TPG. http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/RL/RiliOrgaWlOvLeberTx2015121011.pdf: Bundesärztekammer. Accessed April 2016.
12. Schlitt HJ, Loss M, Scherer MN, Becker T, Jauch KW, Nashan B, et al. [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres; in German]. Z Gastroenterol 2011;49:30–38.
13. Toso C, Mazzaferro V, Bruix J, Freeman R, Mentha G, Majno P. Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant 2014;14:2221–2227.
14. Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016;150:835–853.
15. Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, et al.; for A2ALL Study Group. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant 2012;12:2997–3007.
16. Sharpton SR, Feng S, Hameed B, Yao F, Lai JC. Combined effects of recipient age and Model for End-Stage Liver Disease score on liver transplantation outcomes. Transplantation 2014;98:557–562.
17. Pezzati D, Ghinolfi D, De Simone P, Balzano E, Filipponi F. Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol 2015;7:2636–2647.
18. Hackl C, Schlitt HJ, Melter M, Knoppke B, Loss M. Current developments in pediatric liver transplantation. World J Hepatol 2015;7:1509–1520.
19. Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg 2015;262:465–475.
20. Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS Jr, Merion RM, et al. Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). J Hepatol 2015;62:346–353.
21. Richter-Kuhlmann E. Überprüfung der Lebertransplantationszentren - Deutliche Verstöße in vier Zentren. Dtsch Arztebl Int 2013;110:A1663–A1664.
22. German Foundation for Organ Transplantation. [Umfragen zur Organspende]. https://www.dso.de/organspende-und-transplantation/thema-organspende/umfragen-zur-organspende.html. Accessed April 2016.
23. Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011;365:1790–1800.
24. Vanlemmens C, Di Martino V, Milan C, Messner M, Minello A, Duvoux C, et al.; for TRANSCIAL Study Group. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial. Ann Intern Med 2009;150:153–161.
25. Siegmund-Schultze N. [Transplantationsmedizin: Die Verteilung des Mangels]. Dtsch Arztebl Int 2014;111:A1938–A1939.
26. Seehofer D, Schöning W, Neuhaus P. [Deceased donor liver transplantation; in German]. Chirurg 2013;84:391–397.
27. Nijboer A, Ulrich F, Bechstein WO, Schnitzbauer AA. Volume and outcome relation in German liver transplant centers: what lessons can be learned? Transplant Res 2014;3:5.